- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 26.01M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 23.29M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 18.14M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$6.99M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$5.65M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $138.6K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $58.73K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$13.23M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$17.51M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$9.62M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$5.5M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $16.29M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $20.04M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $16.56M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $20.33M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.1M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.39M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $3.33M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.82M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.38 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$1.78 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.38 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$1.78 |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $1.29M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $998.22K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$8.82M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$32.33M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$7.06M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$31.9M |
| Revenue | Q1 2026 · Mar 31, 2025 | $39.99K |